CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-26 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +7,866 | $25.01 | $197K | 62,511 |
| 2026-10-26 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −7,866 | $37.69 | $296K | 54,645 |
| 2026-10-26 | Gheuens Sarah Chief Medical Officer | Option exercise · Stock options (right to buy) 10b5-1 | −7,866 | 16,275 | ||
| 2026-10-22 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +500 | $25.01 | $13K | 55,145 |
| 2026-10-22 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −500 | $37.52 | $19K | 54,645 |
| 2026-10-22 | Gheuens Sarah Chief Medical Officer | Option exercise · Stock options (right to buy) 10b5-1 | −500 | 24,141 | ||
| 2026-10-21 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +1,489 | $25.01 | $37K | 56,134 |
| 2026-10-21 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,489 | $37.53 | $56K | 54,645 |
| 2026-10-21 | Gheuens Sarah Chief Medical Officer | Option exercise · Stock options (right to buy) 10b5-1 | −1,489 | 24,641 | ||
| 2026-08-04 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −30,000 | $30.48 | $914K | 54,645 |
| 2026-07-08 | Backstrom Jay T. Director | Grant or award | +1,447 | 1,447 | ||
| 2026-07-08 | Backstrom Jay T. Director | Option exercise · Restricted stock units | −1,447 | 2,894 | ||
| 2026-07-01 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +8,375 | 88,652 | ||
| 2026-07-01 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −4,007 | $37.56 | $151K | 84,645 |
| 2026-07-01 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −8,375 | 0 | ||
| 2026-06-18 | Ballal Rahul D. Director | Option exercise | +2,816 | 15,230 | ||
| 2026-06-18 | Ballal Rahul D. Director | Option exercise · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | Ballal Rahul D. Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | Ballal Rahul D. Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2026-06-18 | CAPELLO JEFFREY D Director | Option exercise | +2,816 | 10,865 |
Page 1 of 48 · 941 trades